Tertius News is an AI-native newsroom: an AI model reads the source articles linked below — on this story, all of them from one outlet — and extracts what that outlet reported, claim by claim. How this works →

Tanzania: Tanzania Lures Pharma Giants At Shanghai Expo

Tanzania is courting global pharmaceutical manufacturers at the CPHI China 2026 exhibition in Shanghai, promoting a stable market and regulatory reforms. According to reports by AllAfrica, the government delegation highlighted projected growth in demand, improved regulatory standards, and new industrial zones to attract investment.

By Tertius News AI Desk 1 outlet · 2 articles Version 1 Coverage Jun 18, 2026 Published Aug 14

Lead

Tanzania is renewing its bid to become a pharmaceutical manufacturing hub for Africa, with a delegation attending the CPHI China 2026 International Pharmaceutical Exhibition in Shanghai to attract global investors. According to reports by AllAfrica, the delegation, led by Health Deputy Permanent Secretary responsible for Pharmaceuticals and Medical Devices Emmanuel Tayari, is promoting the country's improving investment climate and its growing medicine demand to manufacturers and industry partners.

Tanzania's Delegation and Goals

At the exhibition, which one report described as one of Asia's largest pharmaceutical trade fairs, Tanzania is represented by the Pharmaceutical and Medical Devices Investment Acceleration Taskforce. This unit is meant to promote investment opportunities and engage international manufacturers on setting up operations in Tanzania, according to an AllAfrica report. The delegation is meeting with manufacturers, active pharmaceutical ingredient producers, and contract manufacturing organizations.

Tayari said that Tanzania is aiming to attract large-scale production facilities to improve access to essential medicines across Africa, the same report said. Early interest in the pavilion includes investment in vaccines, biologics, injectables, and pharmaceutical raw materials. The country is positioning itself as a future manufacturing hub for domestic and regional markets.

The reports highlighted ongoing reforms in regulation, investment incentives, procurement of local products, and industrial zone development. AllAfrica quoted Tayari as saying the government is improving the investment climate to attract global manufacturers into drug production, raw materials, and health-related industries.

Market Data and Projections

According to an AllAfrica report, domestic medicine demand is projected to rise from about 131 million packs in 2024-2025 to more than 600 million packs by 2039-2040. The report also said that the Medical Stores Department purchases health commodities worth about 491 million US dollars annually, providing a "strong and stable market." Another report added that the Tanzania Medicines and Medical Devices Authority (TMDA) has reached WHO Maturity Level 3, which is meant to boost investor confidence.

The government has reduced registration time for local medicines to 60 days and has established pharmaceutical industrial zones in Mloganzila and Kibaha, according to the reports. Tanzania is described as strategically positioned to serve a regional market of more than 780 million people across the East African Community and Southern African Development Community.

broader Context

Tanzania's goal is to expand domestic production, reduce imports, and strengthen its role as a regional supply hub in East and Southern Africa. The government has voiced commitment to fair competition and protection of local industry, urging investors to take advantage of the opportunities outlined at the exhibition.

The CPHI China exhibition is a major event for global pharmaceutical industry players and investors, and it is a platform for countries like Tanzania to present themselves to a wide audience. The participation aligns Tanzania's public procurement with its ambition to attract investment in vaccines, biologics, injectables, and pharmaceutical raw materials.

How this outlet told it

AllAfrica as of Jun 18, 2026, 7:30 PM UTC

Framing: Tanzania's efforts to attract pharmaceutical investors — Positive and promotional

Facts Included:

Tanzania is participating in the CPHI China 2026 International Pharmaceutical Exhibition
The country is represented by the Pharmaceutical and Medical Devices Investment Acceleration Taskforce
Tanzania aims to attract large-scale production facilities to improve access to essential medicines across Africa
Reforms are ongoing in regulation, investment incentives, procurement of local products, and industrial zone development

Read the source article →

AllAfrica as of Jun 18, 2026, 7:30 PM UTC

Framing: Tanzania's efforts to establish itself as a leading pharmaceutical manufacturing hub — Positive and encouraging

Facts Included:

Tanzania is accelerating efforts to establish itself as a leading pharmaceutical manufacturing hub in Africa
Domestic medicine demand is projected to rise from about 131 million packs in 2024-2025 to more than 600 million packs by 2039-2040
The Medical Stores Department purchases health commodities worth about 491 million US dollars annually
The Tanzania Medicines and Medical Devices Authority (TMDA) has reached WHO Maturity Level 3

Read the source article →

What was claimed, and who backed it

Each row is one claim, attributed to the outlet whose wording states it most clearly. Confidence rates how directly the source text states the claim — explicit and unhedged rates high; hedged, pieced-together, or internally inconsistent statements rate lower. It does not measure whether the claim is true. Status counts the distinct outlets we found asserting it — so a single-source claim can still show high confidence, and a multi-source claim can show medium. Every one of those outlets is named beside the status, so you can check the count against the list. For claims extracted before we began storing that list, the row says so: it names the outlet the claim is quoted from and states that we have not recorded which outlets backed it. Outlets wrote at different times, so a figure that evolves — a casualty count, for example — can legitimately differ between rows; check the "as of" time next to each claim's source.

Claim	Confidence	Status
ClaimTanzania is participating in the CPHI China 2026 International Pharmaceutical Exhibition. The country is represented by the Pharmaceutical and Medical Devices Investment Acceleration Taskforce.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimTanzania aims to attract large-scale production facilities to improve access to essential medicines across Africa.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimReforms are ongoing in regulation, investment incentives, procurement of local products, and industrial zone development.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimTanzania is accelerating efforts to establish itself as a leading pharmaceutical manufacturing hub in Africa.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimDomestic medicine demand is projected to rise from about 131 million packs in 2024-2025 to more than 600 million packs by 2039-2040.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimThe Medical Stores Department purchases health commodities worth about 491 million US dollars annually.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC
ClaimThe Tanzania Medicines and Medical Devices Authority (TMDA) has reached WHO Maturity Level 3.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Jun 18, 2026, 7:30 PM UTC

Transparency & Audit Trail

1 outlet · 2 articles consulted: AllAfrica 7 claims extracted Version 1 Written 2026-08-14